Compare VIASP & XOMAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Via Renewables Inc. 8.75% Series A Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Stock
Current Price
| Metric | VIASP | XOMAP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 162 | 14 |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | VIASP | XOMAP |
|---|---|---|
| Price | $25.59 | $25.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.4K | 2.4K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.88 | $25.14 |
| 52 Week High | $26.54 | $27.30 |
| Indicator | VIASP | XOMAP |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 50.62 |
| Support Level | $25.49 | $25.40 |
| Resistance Level | $25.59 | $25.58 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 94.94 | 71.79 |
Via Renewables Inc is an independent retail energy services company. The company provides residential and commercial customers in competitive U.S. markets with electricity and natural gas sourced from wholesale providers, offering an alternative to traditional utilities. It bills customers based on consumption at fixed or variable prices, while delivery is handled by local regulated utility companies through existing infrastructure. Its segments are the Retail Electricity segment, which generates the majority of revenue and involves purchasing electricity through physical and financial transactions with market counterparties and ISOs, and the Retail Natural Gas segment, which similarly procures and supplies natural gas to customers under fixed- and variable-price contracts.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.